Latest Insider Transactions at Jazz Pharmaceuticals PLC (JAZZ)
This section provides a real-time view of insider transactions for Jazz Pharmaceuticals PLC (JAZZ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Jazz Pharmaceuticals plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Jazz Pharmaceuticals plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 08
2022
|
Patrick G Enright Director |
SELL
Open market or private sale
|
Direct |
1,089
-4.33%
|
$165,528
$152.33 P/Share
|
|
Aug 08
2022
|
Peter Gray Director |
SELL
Open market or private sale
|
Direct |
1,179
-7.65%
|
$179,208
$152.32 P/Share
|
|
Aug 08
2022
|
Heather Ann Mc Sharry Director |
SELL
Open market or private sale
|
Direct |
6,679
-17.68%
|
$1,021,887
$153.46 P/Share
|
|
Aug 08
2022
|
Heather Ann Mc Sharry Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+28.02%
|
$440,000
$55.28 P/Share
|
|
Aug 08
2022
|
Kenneth W O'Keefe Director |
SELL
Open market or private sale
|
Direct |
1,089
-4.91%
|
$165,528
$152.33 P/Share
|
|
Aug 08
2022
|
Anne O Riordan Director |
SELL
Open market or private sale
|
Direct |
1,089
-9.22%
|
$165,528
$152.32 P/Share
|
|
Aug 08
2022
|
Norbert G Riedel Director |
SELL
Open market or private sale
|
Direct |
1,089
-8.4%
|
$165,528
$152.32 P/Share
|
|
Aug 08
2022
|
Mark Douglas Smith Director |
SELL
Open market or private sale
|
Direct |
1,089
-15.6%
|
$165,528
$152.32 P/Share
|
|
Aug 08
2022
|
Catherine A. Sohn Director |
SELL
Open market or private sale
|
Direct |
1,089
-7.71%
|
$165,528
$152.32 P/Share
|
|
Aug 08
2022
|
Rick E Winningham Director |
SELL
Open market or private sale
|
Direct |
1,089
-11.23%
|
$165,528
$152.32 P/Share
|
|
Aug 05
2022
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,321
-4.18%
|
$202,113
$153.72 P/Share
|
|
Aug 05
2022
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,561
+26.84%
|
-
|
|
Aug 05
2022
|
Patrick G Enright Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,561
+9.23%
|
-
|
|
Aug 05
2022
|
Peter Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,561
+14.25%
|
-
|
|
Aug 05
2022
|
Heather Ann Mc Sharry Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,561
+15.72%
|
-
|
|
Aug 05
2022
|
Seamus Mulligan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,561
+0.22%
|
-
|
|
Aug 05
2022
|
Kenneth W O'Keefe Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,561
+10.36%
|
-
|
|
Aug 05
2022
|
Anne O Riordan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,561
+17.83%
|
-
|
|
Aug 05
2022
|
Norbert G Riedel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,561
+16.5%
|
-
|
|
Aug 05
2022
|
Norbert G Riedel Director |
SELL
Open market or private sale
|
Direct |
8,000
-43.48%
|
$1,240,000
$155.87 P/Share
|
|
Aug 05
2022
|
Norbert G Riedel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+30.3%
|
$440,000
$55.28 P/Share
|
|
Aug 05
2022
|
Mark Douglas Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,561
+26.84%
|
-
|
|
Aug 05
2022
|
Catherine A. Sohn Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,561
+15.35%
|
-
|
|
Aug 05
2022
|
Rick E Winningham Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,561
+20.89%
|
-
|
|
Aug 04
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
531
-4.48%
|
$82,305
$155.0 P/Share
|
|
Aug 04
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
531
+4.29%
|
$57,879
$109.45 P/Share
|
|
Aug 01
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
7,301
-0.51%
|
$1,124,354
$154.55 P/Share
|
|
Aug 01
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+1.31%
|
$504,400
$52.98 P/Share
|
|
Jul 12
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
532
-4.49%
|
$82,460
$155.0 P/Share
|
|
Jul 12
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
532
+4.3%
|
$57,988
$109.45 P/Share
|
|
Jul 05
2022
|
Christopher J. Tovey EVP, COO & Managing Director E |
SELL
Open market or private sale
|
Direct |
5,209
-13.86%
|
$833,440
$160.0 P/Share
|
|
Jul 05
2022
|
Christopher J. Tovey EVP, COO & Managing Director E |
BUY
Exercise of conversion of derivative security
|
Direct |
4,032
+16.87%
|
$0
$0.02 P/Share
|
|
Jul 05
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
8,775
-0.61%
|
$1,377,675
$157.68 P/Share
|
|
Jul 05
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.62%
|
$446,200
$46.83 P/Share
|
|
Jun 27
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
8,508
-42.93%
|
$1,318,740
$155.0 P/Share
|
|
Jun 27
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,508
+30.04%
|
$927,372
$109.45 P/Share
|
|
Jun 08
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
8,487
-24.24%
|
$1,315,485
$155.0 P/Share
|
|
Jun 08
2022
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,835
+22.77%
|
$636,015
$109.45 P/Share
|
|
Jun 07
2022
|
Kim Sablich EVP, GM of U.S. |
SELL
Open market or private sale
|
Direct |
2,441
-1.85%
|
$366,150
$150.51 P/Share
|
|
Jun 06
2022
|
Kim Sablich EVP, GM of U.S. |
SELL
Open market or private sale
|
Direct |
1,388
-4.86%
|
$210,976
$152.15 P/Share
|
|
Jun 06
2022
|
Kim Sablich EVP, GM of U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,759
-5.8%
|
$262,091
$149.25 P/Share
|
|
Jun 06
2022
|
Robert Iannone EVP, Global Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,295
-3.29%
|
$192,955
$149.25 P/Share
|
|
Jun 06
2022
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,000
-3.07%
|
$152,000
$152.15 P/Share
|
|
Jun 02
2022
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
131
-2.06%
|
$19,650
$150.26 P/Share
|
|
Jun 02
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.28%
|
$150,000
$150.0 P/Share
|
|
Jun 01
2022
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,362
-0.36%
|
$935,214
$147.62 P/Share
|
|
Jun 01
2022
|
Bruce C Cozadd Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,700
+2.64%
|
$446,200
$46.83 P/Share
|
|
May 11
2022
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
722
-10.38%
|
$106,134
$147.51 P/Share
|
|
May 10
2022
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
161
-0.49%
|
-
|
|
May 10
2022
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
273
-3.78%
|
$39,312
$144.18 P/Share
|